Christopher C. Caillouet

Array ( [id] => 4899901 [patent_doc_number] => 20080119515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis' [patent_app_type] => utility [patent_app_number] => 10/547959 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13257 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119515.pdf [firstpage_image] =>[orig_patent_app_number] => 10547959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866108 [patent_doc_number] => 20060100239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Method for producing optically active amines' [patent_app_type] => utility [patent_app_number] => 10/547419 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16492 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100239.pdf [firstpage_image] =>[orig_patent_app_number] => 10547419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890469 [patent_doc_number] => 20060276653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Process for producing quinoline compound' [patent_app_type] => utility [patent_app_number] => 10/551777 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4151 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276653.pdf [firstpage_image] =>[orig_patent_app_number] => 10551777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 303751 [patent_doc_number] => 07534890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-19 [patent_title] => 'Process for preparing 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1H)-quinolin-2-one salt, useful as an andrenoceptor agonist' [patent_app_type] => utility [patent_app_number] => 10/546941 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5828 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534890.pdf [firstpage_image] =>[orig_patent_app_number] => 10546941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7151281 [patent_doc_number] => 20040171662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration' [patent_app_type] => new [patent_app_number] => 10/785070 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7533 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171662.pdf [firstpage_image] =>[orig_patent_app_number] => 10785070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716165 [patent_doc_number] => 20060079528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors' [patent_app_type] => utility [patent_app_number] => 10/546153 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39764 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079528.pdf [firstpage_image] =>[orig_patent_app_number] => 10546153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4575231 [patent_doc_number] => 07825130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'PTEN inhibitor or Maxi-K channels opener' [patent_app_type] => utility [patent_app_number] => 10/546632 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4477 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825130.pdf [firstpage_image] =>[orig_patent_app_number] => 10546632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107712 [patent_doc_number] => 20070066590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism' [patent_app_type] => utility [patent_app_number] => 10/546665 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 39639 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066590.pdf [firstpage_image] =>[orig_patent_app_number] => 10546665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913202 [patent_doc_number] => 20050176960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Resolution of racemates of methyl alpha-5-[4,5,6,7-tetrahydro[3,2-C]thienopyridyl]-(2-chlorophenyl) acetate' [patent_app_type] => utility [patent_app_number] => 10/779724 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5818 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176960.pdf [firstpage_image] =>[orig_patent_app_number] => 10779724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844588 [patent_doc_number] => 20060122225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Method for producing an optically active tetrahydroquinoline' [patent_app_type] => utility [patent_app_number] => 10/545899 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17983 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122225.pdf [firstpage_image] =>[orig_patent_app_number] => 10545899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468874 [patent_doc_number] => 20040167167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Biphenyl derivatives' [patent_app_type] => new [patent_app_number] => 10/779157 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63165 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167167.pdf [firstpage_image] =>[orig_patent_app_number] => 10779157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691560 [patent_doc_number] => 07074933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Urea and thiourea derivatives' [patent_app_type] => utility [patent_app_number] => 10/775464 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8713 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074933.pdf [firstpage_image] =>[orig_patent_app_number] => 10775464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348212 [patent_doc_number] => 20040192913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Process for the racemization of chiral quinazolinones' [patent_app_type] => new [patent_app_number] => 10/773602 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5855 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192913.pdf [firstpage_image] =>[orig_patent_app_number] => 10773602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691461 [patent_doc_number] => 20070232572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Chemical derivatives as antitelomerase agents which bind specifically to the G-quadruplex DNA structures and their application as a specific anticancer agent' [patent_app_type] => utility [patent_app_number] => 10/773806 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14477 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232572.pdf [firstpage_image] =>[orig_patent_app_number] => 10773806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743623 [patent_doc_number] => 20060089348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Substituted quinoline-4-carboxylic hydrazides as nk-2/nk-3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/544440 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6477 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089348.pdf [firstpage_image] =>[orig_patent_app_number] => 10544440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656846 [patent_doc_number] => 20060142582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Crystalline forms of pitavastatin calcium' [patent_app_type] => utility [patent_app_number] => 10/544752 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4486 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142582.pdf [firstpage_image] =>[orig_patent_app_number] => 10544752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835440 [patent_doc_number] => 20060247271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23' [patent_app_type] => utility [patent_app_number] => 10/543974 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7256 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247271.pdf [firstpage_image] =>[orig_patent_app_number] => 10543974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163319 [patent_doc_number] => 20050085467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Androgen receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/758582 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8370 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085467.pdf [firstpage_image] =>[orig_patent_app_number] => 10758582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163316 [patent_doc_number] => 20050085466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Androgen receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/758581 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9705 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085466.pdf [firstpage_image] =>[orig_patent_app_number] => 10758581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378694 [patent_doc_number] => 20040220218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Chlorinated heterocyclic compounds and methods of synthesis' [patent_app_type] => new [patent_app_number] => 10/749835 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11081 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220218.pdf [firstpage_image] =>[orig_patent_app_number] => 10749835 [rel_patent_id] =>[rel_patent_doc_number] =>)